1. Home
  2. STRA vs AUPH Comparison

STRA vs AUPH Comparison

Compare STRA & AUPH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • STRA
  • AUPH
  • Stock Information
  • Founded
  • STRA 2017
  • AUPH 1993
  • Country
  • STRA United States
  • AUPH Canada
  • Employees
  • STRA N/A
  • AUPH N/A
  • Industry
  • STRA Other Consumer Services
  • AUPH Biotechnology: Pharmaceutical Preparations
  • Sector
  • STRA Real Estate
  • AUPH Health Care
  • Exchange
  • STRA Nasdaq
  • AUPH Nasdaq
  • Market Cap
  • STRA 1.8B
  • AUPH 1.6B
  • IPO Year
  • STRA 1996
  • AUPH 1999
  • Fundamental
  • Price
  • STRA $79.66
  • AUPH $15.33
  • Analyst Decision
  • STRA Buy
  • AUPH Strong Buy
  • Analyst Count
  • STRA 2
  • AUPH 3
  • Target Price
  • STRA $96.50
  • AUPH $17.67
  • AVG Volume (30 Days)
  • STRA 152.5K
  • AUPH 1.9M
  • Earning Date
  • STRA 11-06-2025
  • AUPH 11-04-2025
  • Dividend Yield
  • STRA 3.00%
  • AUPH N/A
  • EPS Growth
  • STRA N/A
  • AUPH N/A
  • EPS
  • STRA 4.81
  • AUPH 0.55
  • Revenue
  • STRA $1,256,466,000.00
  • AUPH $265,808,000.00
  • Revenue This Year
  • STRA $5.58
  • AUPH $17.33
  • Revenue Next Year
  • STRA $4.11
  • AUPH $14.31
  • P/E Ratio
  • STRA $16.63
  • AUPH $27.90
  • Revenue Growth
  • STRA 3.74
  • AUPH 20.62
  • 52 Week Low
  • STRA $72.25
  • AUPH $6.55
  • 52 Week High
  • STRA $104.51
  • AUPH $16.20
  • Technical
  • Relative Strength Index (RSI)
  • STRA 51.04
  • AUPH 71.77
  • Support Level
  • STRA $73.65
  • AUPH $13.34
  • Resistance Level
  • STRA $81.65
  • AUPH $15.98
  • Average True Range (ATR)
  • STRA 2.66
  • AUPH 0.82
  • MACD
  • STRA 0.39
  • AUPH 0.23
  • Stochastic Oscillator
  • STRA 58.12
  • AUPH 79.95

About STRA Strategic Education Inc.

Strategic Education Inc. is an education services company that provides access to high-quality education through campus-based and online post-secondary education offerings, as well as through programs to develop job-ready skills for high-demand markets. The company operates through wholly-owned subsidiaries Strayer University and Capella University, both accredited post-secondary institutions of higher education located in the United States, as well as Torrens University, an accredited post-secondary institution of higher education located in Australia. It provide employees with access to affordable and industry relevant training, certificate, and degree programs. The reportable segments of the company are U.S. Higher Education, Australia/New Zealand and Education Technology Services.

About AUPH Aurinia Pharmaceuticals Inc

Aurinia Pharmaceuticals Inc is a biopharmaceutical company focused on delivering therapies to people living with autoimmune diseases with high unmet medical needs. The company developed LUPKYNIS (voclosporin), the first FDA-approved oral therapy for the treatment of adult patients with active lupus nephritis. It is also developing AUR200, a dual inhibitor of B cell activating factor (BAFF) and a proliferation-inducing ligand (APRIL), for the potential treatment of autoimmune diseases.

Share on Social Networks: